| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +15.2 M | 98.7% | $21.00 | +$320 M |
| Sells | 4 | -208 K | 1.3% | $19.58 | -$4.07 M |
| Net | -3 | +15 M | 97.3% | +$316 M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Gilead Sciences, Inc. | 10%+ Owner | $631 M | +$320 M | +103% | Jan 29, 2024 |
| Terry J. Rosen | Chief Executive Officer, Director | $67.1 M | Jun 15, 2024 | ||
| Juan C. Jaen | President | $25.8 M | -$683 K | -2.58% | Jun 15, 2024 |
| Yasunori Kaneko | Director | $16.1 M | Jun 6, 2024 | ||
| Jennifer Jarrett | Chief Operating Officer | $3.45 M | -$3.34 M | -49.2% | Jun 15, 2024 |
| Kathryn E. Falberg | Director | $2.76 M | Jun 6, 2024 | ||
| Dimitry SA Nuyten | Chief Medical Officer | $1.98 M | Jan 23, 2024 | ||
| Carolyn Tang | General Counsel | $1.89 M | Jun 15, 2024 | ||
| Robert Goeltz II | Chief Financial Officer | $1.55 M | -$40.1 K | -2.52% | Jan 23, 2024 |
| David L. Lacey | Director | $1.01 M | Jun 6, 2024 | ||
| Antoni Ribas | Director | $683 K | Jun 6, 2024 | ||
| Andrew J. Perlman | Director | $515 K | Jun 6, 2024 | ||
| Patrick Machado | Director | $444 K | Jun 6, 2024 | ||
| Nicole Lambert | Director | $421 K | Jun 6, 2024 | ||
| William Grossman | Chief Medical Officer | $414 K | Jun 16, 2021 | ||
| Alexander Azoy | Chief Accounting Officer | $381 K | -$4.22 K | -1.09% | Jan 23, 2024 |
| Johanna Mercier | Director | $0 | Jan 29, 2024 | ||
| Linda Slanec Higgins | Director | Aug 10, 2021 |
| Insider | Class | Transaction | % | Value $ | Price $ | Shares | Shares Owned | Date | Ownership |
|---|